| 000 | 00867 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250516042252.0 | ||
| 264 | 0 | _c20110722 | |
| 008 | 201107s 0 0 jpn d | ||
| 022 | _a0047-1852 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatanabe, Takuo | |
| 245 | 0 | 0 |
_a[AGE inhibitors]. _h[electronic resource] |
| 260 |
_bNihon rinsho. Japanese journal of clinical medicine _cNov 2010 |
||
| 300 |
_a155-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aDiabetes Complications _xdrug therapy |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
| 700 | 1 | _aYamamoto, Hiroshi | |
| 773 | 0 |
_tNihon rinsho. Japanese journal of clinical medicine _gvol. 68 Suppl 9 _gp. 155-9 |
|
| 999 |
_c20917183 _d20917183 |
||